Medication-assisted treatment, usually shortened to MAT, is one of the most evidence-backed tools available for treating opioid use disorder and alcohol use disorder, and it's also one of the most misunderstood. Some people hear "medication" and assume it means trading one substance for another. Others aren't sure how MAT fits alongside therapy, or which medications are actually used and why.
Methadone is dispensed under federal Opioid Treatment Program certification, along with the other medications, at an accredited inpatient rehab center in Red Hook. Here is what MAT actually is, how it works alongside the rest of a treatment program, and what patients considering it should understand before starting.
What Medication-Assisted Treatment Actually Is
MAT uses FDA-approved medications, combined with counseling and behavioral therapy, to treat substance use disorder. The medications work by reducing cravings and withdrawal symptoms, which allows a patient to engage more fully in the therapeutic work of recovery instead of spending all their energy fighting physical withdrawal or intense cravings.
This is a different mechanism than simply substituting one drug for another. Medications used in MAT are administered under medical supervision, at doses calibrated to stabilize a patient rather than produce a high, and they're paired with therapy that addresses the behavioral and psychological drivers of addiction. Research consistently shows that MAT combined with therapy produces better long-term outcomes than either approach used alone.
The Medications Involved and How They Differ
Several medications fall under the MAT umbrella, and each works somewhat differently. Buprenorphine, sold under brand names like Suboxone and Sublocade, partially activates opioid receptors in the brain, enough to reduce cravings and withdrawal without producing the full euphoric effect of opioids like heroin or fentanyl. Sublocade is a monthly injectable version, which some patients prefer over a daily dose.
Methadone works differently, fully activating opioid receptors but at a controlled, long-acting dose that prevents withdrawal without producing intoxication. Because Methadone carries a higher risk profile than buprenorphine, dispensing it requires federal SAMHSA certification as an Opioid Treatment Program (OTP), a certification not every facility holds. Vivitrol and oral Naltrexone work differently still, blocking opioid receptors entirely so that using opioids while on the medication produces no effect at all. Clonidine, meanwhile, isn't an opioid medication at all; it manages specific withdrawal symptoms like sweating, anxiety, and elevated heart rate. Alcohol dependence follows its own protocol, and the medications used for alcohol withdrawal address seizure risk rather than opioid receptors.
How MAT Fits Into the Larger Treatment Process
MAT typically begins during the detox phase, once withdrawal symptoms start and a clinical team can assess which medication fits a patient's specific situation. The choice depends on the substance involved, the severity of dependence, and the patient's broader medical history, which is why MAT decisions are made individually rather than through a one-size-fits-all protocol.
Once a patient transitions from detox into residential treatment, MAT doesn't stop. The same medication continues throughout the residential phase, running alongside individual therapy, group therapy, and any other clinical work happening during that stay. This continuity matters because starting and stopping a medication introduces exactly the kind of instability that undermines the entire point of MAT in the first place.
Why MAT Continuation After Discharge Is So Important
One of the clearest findings in addiction medicine is that stopping MAT abruptly after inpatient treatment significantly increases the risk of relapse and, in the case of opioid use disorder, overdose. A patient who has been stabilized on Suboxone or Methadone for weeks, then suddenly has no access to that medication after discharge, faces a return of both physical withdrawal and cravings on the same opioid detox timeline their body followed at admission, right at the moment they're trying to reintegrate into daily life without clinical support around them.
This is why MAT continuation has to be built into discharge planning rather than left to chance. A patient leaving on Suboxone or Methadone should have a confirmed outpatient provider ready to continue that prescription before they ever walk out the door, not a general recommendation to "find a doctor" once they're back home.
Not sure whether MAT is right for you, or whether your plan covers it? Call Urban Recovery at (646) 347-1892. Our admissions team will confirm which medications are available on-site, explain how MAT continues after discharge, and verify your insurance at no cost. Nothing about the call commits you to admission.
Common Misconceptions About MAT
A lot of hesitation around MAT comes from the misconception that it's simply replacing one addiction with another. This doesn't hold up against how the medications actually function. Properly dosed MAT medications don't produce the impairing high associated with illicit opioid use, and patients on stable MAT doses can work, drive, and function normally, which is fundamentally different from active addiction.
Another common concern is that MAT is a lifelong commitment with no end point. In reality, the duration of MAT is individualized. Some patients taper off medication after a period of stability under medical guidance, while others benefit from longer-term maintenance, particularly for opioid use disorder, where research supports extended MAT use as protective against relapse rather than something to rush away from.
Who MAT Is Right For
MAT is most clearly indicated for patients with physical dependence on opioids or alcohol, particularly those who have relapsed after previous attempts at unsupported abstinence. A clinically led alcohol detox program pairs medication with monitored withdrawal for that second group. MAT is not automatically the right fit for every patient or every substance, and stimulant dependence, for example, doesn’t currently have an FDA-approved MAT medication in the same way opioid and alcohol use disorder do.
The decision about whether MAT makes sense, and which medication fits, comes down to a full clinical assessment covering the substance involved, prior treatment history, and the patient's overall medical picture. That individualized evaluation, not a generic protocol, is what determines the right path forward for each person.
That assessment starts with one phone call. Our clinical team in Brooklyn, NY, can determine whether MAT fits your situation and which medication makes sense before admission is scheduled. Call (646) 347-1892 to begin.
Related Topics:
- The Importance of Aftercare in Addiction Recovery in Brooklyn
- The Role of Alumni Programs in Long-Term Recovery in Brooklyn
